Oppenheimer & CO Inc Lannett CO Inc Transaction History

Oppenheimer & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 01, 2018	SELL	$14.7 - $24.95 $173,636 - $294,709	-11,812 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$19.9 - $29.25 $60,615 - $89,095	-3,046 Reduced 20.5%	11,812 $274,000
Q3 2017 Nov 09, 2017	BUY	$15.1 - $19.25 $224,355 - $286,016	14,858	14,858 $274,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.